Anthony G. Quinn - President & CEO, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anthony G. Quinn since 27 Dec 2024

Holdings reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 551K $391K $0.71 16 Mar 2022 Direct
Common Stock 266K $189K $0.71 16 Mar 2022 By trusts

Transactions reported by Anthony G. Quinn for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.